Disclosed is a composition, comprising: an isolated polypeptide that is an extracellular ligand-binding portion of a human p75 tumour necrosis factor receptor fused to the Fc region of a human IgGl; and salt in an amount sufficient to prevent aggregation of the isolated polypeptide, thereby stabilizing the composition, wherein the composition does not contain added free amino acids.